Publications by authors named "Elizabeth C Dees"

Claim this Profile
Q
Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy.
Ryan T Morse, Nathan W Bean, Jacob Hall, Allison Deal, Kirsten A Nyrop, Elizabeth C Dees

Clin Breast Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.
Joseph A Sparano, Michael Crager, Robert J Gray, Gong Tang, Jess Hoag, Elizabeth C Dees

NEJM Evid· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer.
Elizabeth C Wescott, Xiaopeng Sun, Paula Gonzalez-Ericsson, Ann Hanna, Brandie C Taylor, Elizabeth C Dees

Cancer Res Commun· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer.
Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez-Ericsson, Violeta Sanchez, Melinda E Sanders, Elizabeth C Dees

Cancer Discov· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, Chen Jiang, Amy S Etheridge, Elizabeth Claire Dees

Br J Cancer· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Julia C F Quintanilha, Jin Wang, Alexander B Sibley, Chen Jiang, Amy S Etheridge, Elizabeth Claire Dees

Br J Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
Scott A Tomlins, Daniel H Hovelson, Jennifer M Suga, Daniel M Anderson, Han A Koh, Elizabeth C Dees

JCO Precis Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
Darya A Kizub, Jieling Miao, Mark M Schubert, Alexander H G Paterson, Mark Clemons, Elizabeth C Dees

Support Care Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial.
Kathy S Albain, Robert J Gray, Della F Makower, Amir Faghih, Daniel F Hayes, Elizabeth C Dees

J Natl Cancer Inst· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).
Stergios J Moschos, Zeynep Eroglu, Nikhil I Khushalani, Kari L Kendra, George Ansstas, Elizabeth C Dees

Melanoma Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307.
Julie R Gralow, William E Barlow, Alexander H G Paterson, Jieling L M'iao, Danika L Lew, Elizabeth C Dees

J Natl Cancer Inst· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer.
Kirsten A Nyrop, Allison M Deal, Bryce B Reeve, Ethan Basch, Yi Tang Chen, Elizabeth C Dees

Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathy S Albain, Thomas J Saphner, Elizabeth C Dees

JAMA Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Kirsten A Nyrop, Allison M Deal, Kathryn E Reeder-Hayes, Shlomit S Shachar, Bryce B Reeve, Elizabeth C Dees

Cancer· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
Kirsten A Nyrop, Allison M Deal, Shlomit S Shachar, Ethan Basch, Bryce B Reeve, Elizabeth C Dees

Oncologist· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Joseph A Sparano, Robert J Gray, Peter M Ravdin, Della F Makower, Kathleen I Pritchard, Elizabeth C Dees

N Engl J Med· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.
Amanda E D Van Swearingen, Marni B Siegel, Allison M Deal, Maria J Sambade, Alan Hoyle, Elizabeth Claire Dees

Breast Cancer Res Treat· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Elizabeth C Dees

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The incidence and predictive factors for leptomeningeal spread after stereotactic radiation for breast cancer brain metastases.
Orit Kaidar-Person, Allison M Deal, Carey K Anders, Matthew G Ewend, Elizabeth C Dees

Breast J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor.
Huifeng Niu, Hyunjin Shin, Feng Gao, Jacob Zhang, Brittany Bahamon, Elizabeth Claire Dees

EBioMedicine· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informed Consent and Decision Making Among Participants in Novel-Design Phase I Oncology Trials.
Katherine E Reeder-Hayes, Megan C Roberts, Gail E Henderson, Elizabeth C Dees

J Oncol Pract· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.
Joseph A Sparano, Robert J Gray, Della F Makower, Kathleen I Pritchard, Kathy S Albain, Elizabeth C Dees

N Engl J Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I study of the oral antimetabolite, CS-682, administered once daily 5 days per week in patients with refractory solid tumor malignancies.
Jill Gilbert, Michael A Carducci, Sharyn D Baker, Elizabeth C Dees, Ross Donehower

Invest New Drugs· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis